Evaluation of the Efficacy of Ambu® aScope for Intubation in Cancer Tongue
- Conditions
- Difficult Intubation
- Interventions
- Device: ambu ascopeDevice: fibreroptic bronchoscope
- Registration Number
- NCT03999476
- Lead Sponsor
- mahmoud salem soliman
- Brief Summary
This study compares the ascope with standard fiberscope using the nasal route of intubation in patient having sever difficult airway (having posterior one third cancer tongue with fixed mobility)
- Detailed Description
patient will be allocated into two group according to the type of endoscope used group (F) fibro scope group and group (A) the ambu ascope group The timer will be started (T0), when touching the fiberscope or a scope. The standard fiberscope or a scope2 will be introduced through the nostril and advanced through the vocal cords, once carina identified the time will be recorded ( T1) When correct positioning of the trachea confirmed by detection of the end-tidal co2 curve on capnography (T2).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Adult patients of ASA physical status I and II who will be scheduled for posterior third fixed cancer tongue with severe difficult airway requiring naso-tracheal intubation
- aged 18-70 years
- ASA 2 or 4
- pregnant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ambu scope ambu ascope intubation of cancer tongue patients with ambu scope device fiberoptic fibreroptic bronchoscope intubation of cancer tongue patients with fiberoptic device
- Primary Outcome Measures
Name Time Method time of successful intubation 5 minutes measuring time in seconds for reaching carina and time for successful intubation
.
- Secondary Outcome Measures
Name Time Method quality of vision 5 minutes subjective assessment by operator
easiness of intubation 5 minutes subjective assessment
number of intubation trials 30 minutes counting number of intubation in each group
incidence of complications 15 minutes accounting number of desaturation , bleeding , hypoxia .
Trial Locations
- Locations (1)
Kasr Alini Univeristy Hospital
🇪🇬Cairo, Giza, Egypt